# Amgen Inc. (AMGN) — Q3-2017 Earnings Results

**Report date:** 2017-10-25 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2017

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 1.6%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.27 | N/A | +3.33% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Neutral

Overall, management expressed a cautious outlook, acknowledging industry challenges while reaffirming their focus on product development.

**Key quotes:**

> Management highlighted ongoing challenges in the market.

> They emphasized their commitment to innovation despite current pressures.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Amgen's earnings report showed a positive surprise in EPS, which indicates better-than-expected profitability. However, the stock fell by 1.6% following the announcement, likely due to the lack of revenue information and no updated guidance. Investors may be concerned about the company's future performance given the current market challenges mentioned by management.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q3-2017_